DIA420.55-0.96 -0.23%
SPX5,892.58+6.03 0.10%
IXIC19,146.81+136.72 0.72%

12 Health Care Stocks Moving In Wednesday's Intraday Session

Benzinga·05/14/2025 17:06:23
Listen to the news

Gainers

  • Klotho Neurosciences (NASDAQ:KLTO) stock increased by 176.9% to $0.36 during Wednesday's regular session. The company's market cap stands at $10.2 million.
  • bluebird bio (NASDAQ:BLUE) stock moved upwards by 49.89% to $4.96. The market value of their outstanding shares is at $48.5 million.
  • Septerna (NASDAQ:SEPN) stock increased by 41.68% to $9.54. The company's market cap stands at $424.4 million.
  • Innovative Eyewear (NASDAQ:LUCY) shares increased by 36.11% to $2.69. The company's market cap stands at $8.2 million. As per the news, the Q1 earnings report came out yesterday.
  • Basel Medical Group (NASDAQ:BMGL) stock rose 32.0% to $5.94. The company's market cap stands at $111.5 million.
  • Lyra Therapeutics (NASDAQ:LYRA) stock rose 24.61% to $0.12. The company's market cap stands at $7.7 million.

Losers

  • Polyrizon (NASDAQ:PLRZ) shares decreased by 54.4% to $0.01 during Wednesday's regular session.
  • Accelerate Diagnostics (NASDAQ:AXDX) stock decreased by 53.75% to $0.04. The company's market cap stands at $1.0 million.
  • Biodesix (NASDAQ:BDSX) stock fell 39.83% to $0.22. The market value of their outstanding shares is at $31.3 million. As per the press release, Q1 earnings came out yesterday.
  • SILO Pharma (NASDAQ:SILO) shares fell 23.87% to $0.84. The market value of their outstanding shares is at $3.7 million. The company's, Q1 earnings came out 3 days ago.
  • Aspire Biopharma Hldgs (NASDAQ:ASBP) stock decreased by 23.56% to $0.25. The market value of their outstanding shares is at $12.1 million.
  • GRAIL (NASDAQ:GRAL) stock fell 22.45% to $33.27. The market value of their outstanding shares is at $1.1 billion. As per the news, the Q1 earnings report came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.